We have received text from H.R. 5536: Headache Education, Access, Diagnosis, and Care Health Equity Act. This bill was received on 2025-09-19, and currently has 10 cosponsors.
Here is a short summary of the bill:
This bill, officially titled the Headache Education, Access, Diagnosis, and Care Health Equity Act, aims to improve the understanding, diagnosis, and treatment of headache disorders in the United States. The bill outlines several key components:
National Headache Disorders Initiative
The Secretary of Health and Human Services (HHS) is tasked with creating a National Headache Disorders Initiative (NHDI). This initiative will include:
- Developing programs to address the medical, social, and economic impacts of headache disorders.
- Expanding the workforce focused on headache care and research.
- Collaborating with existing federal initiatives focused on related issues.
- Ensuring adequate federal resources are directed toward headache research and services.
- Focusing on research to enhance diagnosis and develop new treatments for headache disorders.
- Improving protocols for diagnosis and care coordination for headache disorders.
- Increasing data collection regarding headache disorders to better inform clinical care and identify disparities.
- Running public awareness campaigns to reduce the stigma associated with headache disorders.
- Collaborating with international organizations on headache-related issues.
Advisory Council on Headache Disorders Research, Care, and Services
The bill establishes an Advisory Council that will advise the Secretary on matters related to headache disorders. Membership will include:
- Federal experts from various health agencies, such as the National Institutes of Health and the Centers for Medicaid and Medicare Services.
- Non-Federal representatives, including patient advocates, healthcare providers specializing in headache disorders, and representatives from affected communities.
The Advisory Council is required to meet quarterly and hold annual research meetings to foster collaboration in headache disorder research.
Data Sharing
Federal agencies that collect data on headache disorders are required to share this information with the Secretary of HHS to help produce a comprehensive understanding of the issues surrounding these disorders.
Annual Report to Congress
The Secretary must submit an annual report to Congress detailing:
- Evaluations of federally funded programs related to headache research and care.
- Data on disparities affecting specific populations.
- Recommendations for actions to improve diagnosis, treatment, public awareness, and reduce stigma.
- A national plan with short- and long-term objectives for addressing headache disorders.
Sunset Clause
The bill includes a provision stating that it will cease to be effective five years after its enactment.
Definition of Headache Disorders
The bill defines “headache disorders” to include a range of conditions primarily characterized by headache, such as migraines, tension headaches, and other specified conditions, ensuring that various populations, including vulnerable groups, are considered in its initiatives.
Relevant Companies
- ABBV : AbbVie is involved in pharmaceuticals that may include treatments for migraine and headache disorders.
- AMGN : Amgen has products related to headache treatment, including migraine therapies.
- TEVA : Teva, as a generics manufacturer, produces medications that may treat headache and pain disorders.
Representative Lori Trahan Bill Proposals
Here are some bills which have recently been proposed by Representative Lori Trahan:
- H.R.5537: Pipeline Accountability Act of 2025
- H.R.5536: HEADACHE Act
- H.R.4868: College Athlete Economic Freedom Act
- H.R.2612: DELETE Act
- H.R.2019: TLDR Act
- H.R.1509: Accelerating Kids’ Access to Care Act of 2025
You can track bills proposed by Representative Lori Trahan on Quiver Quantitative's politician page for Trahan.
Representative Lori Trahan Net Worth
Quiver Quantitative estimates that Representative Lori Trahan is worth $34.1M, as of October 8th, 2025. This is the 41st highest net worth in Congress, per our live estimates.
Trahan has approximately $2.3M invested in publicly traded assets which Quiver is able to track live.
You can track Representative Lori Trahan's net worth on Quiver Quantitative's politician page for Trahan.
Representative Lori Trahan Stock Trading
We have data on up to $30.0K of trades from Representative Lori Trahan, which we parsed from STOCK Act filings. Some of the largest trades include:
- A December 27th, 2021 sale of up to $15K of $GE. The stock has risen 411.86% since then.
You can track Representative Lori Trahan's stock trading on Quiver Quantitative's politician page for Trahan.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
